Onco-Innovations Limited
ONNVF
$2.65
$1.2285.32%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -2.81M | -2.81M | -132.60K | -231.40K | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 1.90M | 1.90M | 1.30K | 113.50K | |
| Change in Net Operating Assets | -290.80K | -290.80K | -60.60K | 0.00 | |
| Cash from Operations | -1.21M | -1.21M | -191.90K | -117.90K | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 2.80K | 2.80K | 0.00 | 66.60K | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 2.80K | 2.80K | 0.00 | 66.60K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -9.10K | -9.10K | -- | -- | |
| Issuance of Common Stock | 2.13M | 2.13M | 220.50K | 79.80K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -60.10K | -60.10K | -- | -- | |
| Cash from Financing | 1.45M | 1.45M | 161.50K | 58.30K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 244.80K | 244.80K | -30.40K | 7.00K | |